92 results on '"Salmonella minnesota"'
Search Results
2. Evaluation of the Antibacterial and Antifungal Capacity of Nanoemulsions Loaded with Synthetic Chalcone Derivatives Di-Benzyl Cinnamaldehyde and Benzyl 4-Aminochalcone.
- Author
-
da Silva Abreu, Flavia Oliveira Monteiro, Holanda, Taysse, Farias do Nascimento, Joice, Nascimento Pinheiro, Henety, Menezes Castelo, Rachel, Silva dos Santos, Hélcio, Benincá, Thais, da Silva Malheiros, Patrícia, Sousa Prado, Júlio César, de Oliveira Fontenelle, Raquel, and de Camargo Forte, Maria Madalena
- Subjects
ANTIBACTERIAL agents ,ANTIFUNGAL agents ,EMULSIONS ,CHALCONE ,BIOAVAILABILITY - Abstract
With the increase in antimicrobial resistance, it has become necessary to explore alternative approaches for combating and preventing diseases. DB-cinnamaldehyde (CNM) and Benzyl4-amino (B4AM) are bioactive compounds derived from chalcones but with restricted solubility in aqueous media. Nanoemulsions can enhance the solubility of compounds and can be a promising alternative in the development of novel antimicrobials, with reduced side effects and prolonged release. The objective of this study was to evaluate the stability of oil-in-water nanoemulsions loaded with two distinct types of chalcones at two different dosages, to propose a stable formulation with antimicrobial properties. Results showed that nanoemulsions presented high encapsulation efficiency, low polydispersity index (PDI) and particle size below 200 nm, indicating that emulsification was a suitable method for nanoemulsion preparation. Nanoemulsions with higher dosages exhibited significant antimicrobial effects when compared to free chalcones and positive controls. Notably, B4AM nanoemulsions at higher dosages showed expressive activity against Salmonella minnesota, with a 420% greater inhibitory response compared to the free form and showing equivalence to the positive control. CNM nanoemulsions showed excellent inhibitory activity at the highest dosage, equivalent to the positive control against S. minnesota and Staphylococcus aureus. The greater number of conjugated bonds in CNM increased the antimicrobial activity in comparison with B4AM, and the formation of nanometric domains enhanced the bioavailability, being a promising alternative for antimicrobial applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. MPLA 衍生物的设计、合成及作为 RBD-hFc 新冠疫苗佐剂的活性研究.
- Author
-
廖攀, 苏诗微, 陈丽清, 罗翔, 廖国超, 孙平华, and 叶连宝
- Abstract
Copyright of Journal of Shenyang Pharmaceutical University is the property of Shenyang Pharmaceutical University and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
4. MPLA衍生物的设计、合成及作为RBD-hFc新冠疫苗佐剂的活性研究.
- Author
-
廖 攀, 苏诗微, 陈丽清, 罗 翔, 廖国超, 孙平华, and 叶连宝
- Abstract
Copyright of Journal of Shenyang Pharmaceutical University is the property of Shenyang Pharmaceutical University and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
5. In This Issue.
- Subjects
- *
MACROPHAGE colony-stimulating factor , *BIOMARKERS , *LYMPHOID tissue , *CHRONIC obstructive pulmonary disease - Abstract
This document provides a comprehensive update on various topics in immunology. The first article discusses the phenotypes and functions of T-helper (Th) cells, specifically Tph cells, which have been found in the synovium of rheumatoid arthritis patients. The second article explores the common immune genes between chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS), suggesting potential diagnostic markers and therapeutic targets. The third article compares the adjuvant activities of lipid A from the commensal bacterium Alcaligenes spp. (ALA) and monophosphoryl lipid A from Salmonella minnesota R595 (MPLA) in mice, finding that ALA is a highly effective adjuvant for intranasal vaccination. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
6. Programming Bordetella pertussis lipid A to promote adjuvanticity.
- Author
-
Fathy Mohamed, Yasmine and Fernandez, Rachel C.
- Subjects
MONONUCLEAR leukocytes ,BORDETELLA pertussis ,TYPE I interferons ,WHOOPING cough ,VACCINE development - Abstract
Background: Bordetella pertussis is the causative agent of whooping cough or pertussis. Although both acellular (aP) and whole-cell pertussis (wP) vaccines protect against disease, the wP vaccine, which is highly reactogenic, is better at preventing colonization and transmission. Reactogenicity is mainly attributed to the lipid A moiety of B. pertussis lipooligosaccharide (LOS). Within LOS, lipid A acts as a hydrophobic anchor, engaging with TLR4-MD2 on host immune cells to initiate both MyD88-dependent and TRIF-dependent pathways, thereby influencing adaptive immune responses. Lipid A variants, such as monophosphoryl lipid A (MPLA) can also act as adjuvants. Adjuvants may overcome the shortcomings of aP vaccines. Results: This work used lipid A modifying enzymes from other bacteria to produce an MPLA-like adjuvant strain in B. pertussis. We created B. pertussis strains with distinct lipid A modifications, which were validated using MALDI-TOF. We engineered a hexa-acylated monophosphorylated lipid A that markedly decreased human TLR4 activation and activated the TRIF pathway. The modified lipooligosaccharide (LOS) promoted IRF3 phosphorylation and type I interferon production, similar to MPLA responses. We generated three other variants with increased adjuvanticity properties and reduced endotoxicity. Pyrogenicity studies using the Monocyte Activation Test (MAT) revealed that these four lipid A variants significantly decreased the IL-6, a marker for fever, response in peripheral blood mononuclear cells (PBMCs). Conclusion: These findings pave the way for developing wP vaccines that are possibly less reactogenic and designing adaptable adjuvants for current vaccine formulations, advancing more effective immunization strategies against pertussis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. A Whole Blood Method for Assessing the Innate Immune Response in Chickens.
- Author
-
Reynolds, Donald L., Simpson, E. Barry, Hille, Matthew M., and Jia, Beibei
- Subjects
IMMUNE response ,NATURAL immunity ,CHICKENS ,INTERLEUKIN-6 ,LIPOPOLYSACCHARIDES - Abstract
Innate immunity is considered the first line of immune defense and is typically an unmeasured response. Here we report a method for evaluating the innate immune response in chickens by using whole blood which has been activated by lipopolysaccharide (LPS) to induce IL-6 release by innate immune cells. It was found that a 24-h LPS activation time interval was the optimum time interval for inducing the IL-6 response. An activation index, defined as the PBS activated control response subtracted from the LPS activated response and then divided by the PBS activated control response and expressed as a percentage, was useful for demonstrating and comparing the magnitude of the innate immune response. Results indicated that there was wide variation between the IL-6 response between individual birds although statistically significant results were obtained for all individual birds at the 24-h activation time interval. The activation indices from all birds were greatest at the 24-h activation time interval. Statistically significant results were achieved when all the data from all birds at the 24-h activation time interval were combined. The cells responsible for the IL-6 response were identified as the peripheral blood monocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Cell-Type-Specific Effect of Innate Immune Signaling on Stress Granules.
- Author
-
Lamichhane, Prem Prasad, Aditi, Xie, Xuping, and Samir, Parimal
- Subjects
STRESS granules ,TOLL-like receptors ,NATURAL immunity ,MACROPHAGES ,FIBROBLASTS - Abstract
Stress granules (SGs) are cytoplasmic membraneless compartments that can form in stressed cells. There is an intricate relationship between SGs and innate immune signaling pathways. A previous study reported that the innate immune signaling mediated by Toll-like receptors (TLRs) can inhibit SGs induced by endoplasmic reticulum stress (ER stress) in bone-marrow-derived macrophages (BMDMs) and the chemotherapy drug oxaliplatin in B16 melanoma cells. We wanted to test if this observation can be generalized to other cell types. First, we recapitulated the results from the previous study showing TLR signaling-mediated inhibition of SGs in BMDMs induced by ER stress. However, SGs formed in response to ER stress were either not inhibited or only very weakly inhibited by TLR4 stimulation in human lung cancer-derived A549 cells, murine immortalized mouse lung fibroblasts (iMLFs) and primary murine mouse lung fibroblasts. This correlated with a weak induction of IKK complex kinase activity by TLR4 stimulation in these cells. SGs formed by sodium arsenite treatment also remained unaffected by TLR4 signaling. Our results indicate that the innate immune signaling-mediated inhibition of SGs is cell-type-dependent, thus opening a new avenue for mechanistic studies of the crosstalk between innate immune and stress signaling pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Molecular mimicry in multisystem inflammatory syndrome in children.
- Author
-
Bodansky, Aaron, Mettelman, Robert C., Sabatino Jr, Joseph J., Vazquez, Sara E., Chou, Janet, Novak, Tanya, Moffitt, Kristin L., Miller, Haleigh S., Kung, Andrew F., Rackaityte, Elze, Zamecnik, Colin R., Rajan, Jayant V., Kortbawi, Hannah, Mandel-Brehm, Caleigh, Mitchell, Anthea, Wang, Chung-Yu, Saxena, Aditi, Zorn, Kelsey, Yu, David J. L., and Pogorelyy, Mikhail V.
- Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a severe, post-infectious sequela of SARS-CoV-2 infection1,2, yet the pathophysiological mechanism connecting the infection to the broad inflammatory syndrome remains unknown. Here we leveraged a large set of samples from patients with MIS-C to identify a distinct set of host proteins targeted by patient autoantibodies including a particular autoreactive epitope within SNX8, a protein involved in regulating an antiviral pathway associated with MIS-C pathogenesis. In parallel, we also probed antibody responses from patients with MIS-C to the complete SARS-CoV-2 proteome and found enriched reactivity against a distinct domain of the SARS-CoV-2 nucleocapsid protein. The immunogenic regions of the viral nucleocapsid and host SNX8 proteins bear remarkable sequence similarity. Consequently, we found that many children with anti-SNX8 autoantibodies also have cross-reactive T cells engaging both the SNX8 and the SARS-CoV-2 nucleocapsid protein epitopes. Together, these findings suggest that patients with MIS-C develop a characteristic immune response to the SARS-CoV-2 nucleocapsid protein that is associated with cross-reactivity to the self-protein SNX8, demonstrating a mechanistic link between the infection and the inflammatory syndrome, with implications for better understanding a range of post-infectious autoinflammatory diseases.A cross-reactive antibody and T cell response is identified in a large portion of patients with multisystem inflammatory syndrome in children. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Immunogenicity of a peptide-based vaccine for measles: a pilot evaluation in a mouse model.
- Author
-
Quach, Huy Quang, Ratishvili, Tamar, Haralambieva, Iana H., Ovsyannikova, Inna G., Poland, Gregory A., and Kennedy, Richard B.
- Subjects
MEASLES vaccines ,VACCINE immunogenicity ,LABORATORY mice ,HLA histocompatibility antigens ,ANIMAL disease models ,T cell receptors - Abstract
Although neutralizing antibody is an established correlate of protection for measles, T cell-mediated responses play at least two critical roles in immunity to measles: first, through provision of 'help' enabling robust humoral immune responses; and second, through clearance of measles virus-infected cells. Previously, we identified 13 measles-derived peptides that bound to human leukocyte antigen (HLA) molecules in Priess cells infected with measles virus. In this study, we evaluated the immunogenicity of these peptides in a transgenic mouse model. Our results demonstrated that these peptides induced Th1-biased immune responses at varying levels. Of the 13 peptides, the top four immunogenic peptides were further selected for a viral challenge study in mice. A vaccine based on a combination of these four peptides reduced morbidity and weight loss after viral challenge compared to placebo. Our results emphasize the potential of T cell-mediated, peptide-based vaccines against measles. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Genomics Characterization of Colistin Resistant Escherichia coli from Chicken Meat—the First Report in the United Arab Emirates.
- Author
-
Habib, Ihab, Mohamed, Mohamed-Yousif Ibrahim, Elbediwi, Mohammed, Ghazawi, Akela, Khan, Mushtaq, Abdalla, Afra, and Lakshmi, Glindya Bhagya
- Published
- 2024
- Full Text
- View/download PDF
12. Bifidobacterium animalis subsp. lactis HN019 live probiotics and postbiotics: production strategies and bioactivity evaluation for potential therapeutic properties.
- Author
-
D'ambrosio, Sergio, Dabous, Azza, Sadiq, Saba, Casillo, Angela, Schiraldi, Chiara, Cassese, Elisabetta, Bedini, Emiliano, Corsaro, Maria Michela, and Cimini, Donatella
- Published
- 2024
- Full Text
- View/download PDF
13. Phenotypic characterization and genomic analysis of a Salmonella phage L223 for biocontrol of Salmonella spp. in poultry.
- Author
-
Khan, Md Abu Sayem, Islam, Zahidul, Barua, Chayan, Sarkar, Md. Murshed Hasan, Ahmed, Md. Firoz, and Rahman, Sabita Rezwana
- Subjects
GENOMICS ,SALMONELLA ,CHICKEN as food ,SALMONELLA enteritidis ,BACTERIOPHAGES ,SALMONELLA typhimurium ,FOOD contamination - Abstract
The escalating incidence of foodborne salmonellosis poses a significant global threat to food safety and public health. As antibiotic resistance in Salmonella continues to rise, there is growing interest in bacteriophages as potential alternatives. In this study, we isolated, characterized, and evaluated the biocontrol efficacy of lytic phage L223 in chicken meat. Phage L223 demonstrated robust stability across a broad range of temperatures (20–70 °C) and pH levels (2–11) and exhibited a restricted host range targeting Salmonella spp., notably Salmonella Typhimurium and Salmonella Enteritidis. Characterization of L223 revealed a short latent period of 30 min and a substantial burst size of 515 PFU/cell. Genomic analysis classified L223 within the Caudoviricetes class, Guernseyvirinae subfamily and Jerseyvirus genus, with a dsDNA genome size of 44,321 bp and 47.9% GC content, featuring 72 coding sequences devoid of antimicrobial resistance, virulence factors, toxins, and tRNA genes. Application of L223 significantly (p < 0.005) reduced Salmonella Typhimurium ATCC 14,028 counts by 1.24, 2.17, and 1.55 log CFU/piece after 2, 4, and 6 h of incubation, respectively, in experimentally contaminated chicken breast samples. These findings highlight the potential of Salmonella phage L223 as a promising biocontrol agent for mitigating Salmonella contamination in food products, emphasizing its relevance for enhancing food safety protocols. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review.
- Author
-
Tajer, Layla, Paillart, Jean-Christophe, Dib, Hanna, Sabatier, Jean-Marc, Fajloun, Ziad, and Abi Khattar, Ziad
- Subjects
ANTIMICROBIAL peptides ,BACTERIAL cell membranes ,DRUG resistance in bacteria ,COMPETITION (Biology) ,DRUG resistance in microorganisms ,BACTERIAL cell walls - Abstract
Antimicrobial resistance (AMR) poses a serious global health concern, resulting in a significant number of deaths annually due to infections that are resistant to treatment. Amidst this crisis, antimicrobial peptides (AMPs) have emerged as promising alternatives to conventional antibiotics (ATBs). These cationic peptides, naturally produced by all kingdoms of life, play a crucial role in the innate immune system of multicellular organisms and in bacterial interspecies competition by exhibiting broad-spectrum activity against bacteria, fungi, viruses, and parasites. AMPs target bacterial pathogens through multiple mechanisms, most importantly by disrupting their membranes, leading to cell lysis. However, bacterial resistance to host AMPs has emerged due to a slow co-evolutionary process between microorganisms and their hosts. Alarmingly, the development of resistance to last-resort AMPs in the treatment of MDR infections, such as colistin, is attributed to the misuse of this peptide and the high rate of horizontal genetic transfer of the corresponding resistance genes. AMP-resistant bacteria employ diverse mechanisms, including but not limited to proteolytic degradation, extracellular trapping and inactivation, active efflux, as well as complex modifications in bacterial cell wall and membrane structures. This review comprehensively examines all constitutive and inducible molecular resistance mechanisms to AMPs supported by experimental evidence described to date in bacterial pathogens. We also explore the specificity of these mechanisms toward structurally diverse AMPs to broaden and enhance their potential in developing and applying them as therapeutics for MDR bacteria. Additionally, we provide insights into the significance of AMP resistance within the context of host–pathogen interactions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Isolation, Characterization, and Complete Genome Sequence of Escherichia Phage KIT06 Which Infects Nalidixic Acid-Resistant Escherichia coli.
- Author
-
Han, Nguyen Song, Harada, Mana, Pham-Khanh, Nguyen Huan, and Kamei, Kaeko
- Subjects
ESCHERICHIA coli ,WHOLE genome sequencing ,DRUG resistance in bacteria ,MEMBRANE proteins ,BACTERIOPHAGES - Abstract
Escherichia coli (E. coli) is one of the most common sources of infection in humans and animals. The emergence of E. coli which acquires resistance to various antibiotics has made treatment difficult. Bacteriophages can be considered promising agents to expand the options for the treatment of antibiotic-resistant bacteria. This study describes the isolation and characterization of Escherichia phage KIT06, which can infect E. coli resistant to the quinolone antibiotic nalidixic acid. Phage virions possess an icosahedral head that is 93 ± 8 nm in diameter and a contractile tail (116 ± 12 nm × 13 ± 5 nm). The phage was found to be stable under various thermal and pH conditions. A one-step growth curve showed that the latent time of the phage was 20 min, with a burst size of 28 particles per infected cell. Phage KIT06 infected 7 of 12 E. coli strains. It inhibited the growth of the host bacterium and nalidixic acid-resistant E. coli. The lipopolysaccharide and outer membrane proteins of E. coli, tsx and btuB, are phage receptors. Phage KIT06 is a new species of the genus Tequatrovirus with a genome of 167,059 bp consisting of 264 open reading frames (ORFs) that encode gene products related to morphogenesis, replication, regulation, and host lysis. The lack of genes encoding integrase or excisionase indicated that this phage was lytic. Thus, KIT06 could potentially be used to treat antibiotic-resistant E. coli using phage therapy. However, further studies are essential to understand its use in combination with other antimicrobial agents and its safe use in such applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Vaccine adjuvants for infectious disease in the clinic.
- Author
-
Goetz, Morgan, Thotathil, Naaz, Zhao, Zongmin, and Mitragotri, Samir
- Subjects
TOLL-like receptor agonists ,VACCINE effectiveness ,GENETIC vectors ,COMMUNICABLE diseases ,IMMUNE response - Abstract
Adjuvants, materials added to vaccines to enhance the resulting immune response, are important components of vaccination that are many times overlooked. While vaccines always include an antigen to tell the body what to vaccinate to, of equal importance the adjuvant provides the how, a significant factor in producing a complete response. The adjuvant space has been slow to develop with the first use of an adjuvant in a licensed vaccine occurring in the 1930s, and remaining the only adjuvant in licensed vaccines for the next 80 years. However, with vaccination at the forefront of protection against new and complex pathogens, it is important to consider all components when designing an effective vaccine. Here we summarize the adjuvant space in licensed vaccines as well as the novel adjuvant space in clinical trials with a specific focus on the materials utilized and their resulting impact on the immune response. We discuss five major categories of adjuvant materials: aluminum salts, nanoparticles, viral vectors, TLR agonists, and emulsions. For each category, we delve into the current clinical trials space, the impact of these materials on vaccination, as well as some of the ways in which they could be improved. Adjuvants present an exciting opportunity to improve vaccine responses and stability, this review will help inform about the current progress of this space. Translational impact statement: In the aftermath of the COVID‐19 pandemic, vaccines for infectious diseases have come into the spotlight. While antigens have always been an important focus of vaccine design, the adjuvant is a significant tool for enhancing the immune response to the vaccine that has been largely underdeveloped. This article provides a broad review of the history of adjuvants and, the current vaccine adjuvant space, and the progress seen in adjuvants in clinical trials. There is specific emphasis on the material landscape for adjuvants and their resulting mechanism of action. Looking ahead, while the novel vaccine adjuvant space features exciting new technologies and materials, there is still a need for more to meet the protective needs of new and complex pathogens. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoire.
- Author
-
Eden, Thomas, Schaffrath, Alessa Z., Wesolowski, Janusz, Stähler, Tobias, Tode, Natalie, Richter, Nathalie, Schäfer, Waldemar, Hambach, Julia, Hermans-Borgmeyer, Irm, Woens, Jannis, Le Gall, Camille M., Wendler, Sabrina, Linke-Winnebeck, Christian, Stobbe, Martina, Budnicki, Iwona, Wanney, Amelie, Heitz, Yannic, Schimmelpfennig, Lena, Schweitzer, Laura, and Zimmer, Dennis
- Subjects
IMMUNOGLOBULINS ,IMMUNOGLOBULIN heavy chains ,B cells ,GENETIC vectors ,TRANSGENIC mice ,MOLECULAR cloning - Abstract
Due to their exceptional solubility and stability, nanobodies have emerged as powerful building blocks for research tools and therapeutics. However, their generation in llamas is cumbersome and costly. Here, by inserting an engineered llama immunoglobulin heavy chain (IgH) locus into IgH-deficient mice, we generate a transgenic mouse line, which we refer to as 'LamaMouse'. We demonstrate that LamaMice solely express llama IgH molecules without association to Igκ or λ light chains. Immunization of LamaMice with AAV8, the receptor-binding domain of the SARS-CoV-2 spike protein, IgE, IgG2c, and CLEC9A enabled us to readily select respective target-specific nanobodies using classical hybridoma and phage display technologies, single B cell screening, and direct cloning of the nanobody-repertoire into a mammalian expression vector. Our work shows that the LamaMouse represents a flexible and broadly applicable platform for a facilitated selection of target-specific nanobodies. Nanobodies are normally made from immunized camelids, Ig transgenic mice or synthetic libraries. In this study, the authors introduce the llama Ig heavy chain locus into mice lacking this locus, thereby generating a line in which nanobodies can be made by direct immunization in the absence of an endogenous antibody repertoire. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Formulation of nanoemulsions enriched with chalcone-based compounds: formulation process, physical stability, and antimicrobial effect.
- Author
-
Abreu, Flavia Oliveira Monteiro da Silva, do Nascimento, Joice Farias, Pinheiro, Henety Nascimento, Castelo, Rachel Menezes, dos Santos, Helcio Silva, Mendes, Francisco Rogênio da Silva, Cavalcanti, Bruno Côelho, Mendoza, Maria Fernanda Madrid, Benincá, Thais, Malheiros, Patricia da Silva, and Forte, Maria Madalena de Camargo
- Subjects
GUM arabic ,CHALCONE ,NANOPARTICLES ,DRUG resistance in bacteria ,PATHOGENIC bacteria ,ALGINIC acid ,SALMONELLA diseases - Abstract
Salmonellosis has a high power of dissemination and dispersion of strains resistant to conventional antimicrobials, which constitutes a public health problem. Nanoemulsions can enhance the efficacy of antimicrobials compared to conventional drug administration, with reduced side effects and prolonged release. The aim of this study is to produce nanoemulsions by high-energy method using alginate and gum arabic matrices to evaluate the effect of three types of chalcone on the inhibition of S. minnesota and to propose an alternative candidate to overcome antibiotic resistance in pathogenic bacteria. Nanoemulsions with nanosized spherical particles obtained with gum arabic are more stable over time than those with alginate by the lower sedimentation values and the smaller size of the droplets. The antibacterial inhibition test against S. minnesota revealed that the chalcone 1,5-di(thiophen-2-yl)penta-1,4-dien-3-one (TIOF) and 1,5-bis(4-ethoxyphenyl)penta-1,4-dien-3-one (ETOX) and their nanoemulsions presented an equivalent effect compared to the positive control (sulfamethoxazole-trimethoprim). On the other hand, although the chalcone 1,9-diphenylnone-1,3,6,8-tetraen-5-one (CNM) presented low inhibitory capacity, they presented an increasing in the inhibitory activity of 164%, when they were in the nanoemulsion form in comparison with the free form, and equivalent activity to the positive control. Nanoemulsions of gum arabic with 1,9-diphenylnone-1,3,6,8-tetraen-5-one (CNM) also presented lower cytotoxic effects, being a promising inhibitor against S. minnesota. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with high potency.
- Author
-
Walle, Lieselotte Vande, Said, Madhukar, Paerewijck, Oonagh, Bertoni, Arinna, Gattorno, Marco, Linclau, Bruno, and Lamkanfi, Mohamed
- Published
- 2024
- Full Text
- View/download PDF
20. The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.
- Author
-
Shi-Yu Qi, Miao-Miao Yang, Chong-Yang Li, Kun Yu, and Shou-Long Deng
- Subjects
HUMAN papillomavirus ,TOLL-like receptor agonists ,VIRUS diseases ,CANCER treatment ,PAPILLOMAVIRUS diseases ,GENITAL warts - Abstract
Infection with human papillomavirus (HPV) typically leads to cervical cancer, skin related cancers and many other tumors. HPV is mainly responsible for evading immune tumor monitoring in HPV related cancers. Toll like receptors (TLRs) are particular pattern recognition molecules. When the body is facing immune danger, it can lead to innate and direct adaptive immunity. TLR plays an important role in initiating antiviral immune responses. HPV can affect the expression level of TLR and interfere with TLR related signaling pathways, resulting in sustained viral infection and even carcinogenesis. This paper introduces the HPV virus and HPV related cancers. We discussed the present comprehension of TLR, its expression and signaling, as well as its role in HPV infection. We also provided a detailed introduction to immunotherapy methods for HPV related diseases based on TLR agonists. This will provide insights into methods that support the therapeutic method of HPV related conditions with TLR agonists [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. High production of IL-12 by human dendritic cells stimulated with combinations of pattern-recognition receptor agonists.
- Author
-
Gilmour, Brian C., Corthay, Alexandre, and Øynebråten, Inger
- Subjects
DENDRITIC cells ,IMMUNOMODULATORS ,TOLL-like receptors ,VACCINE effectiveness ,CANCER vaccines ,QUORUM sensing - Abstract
The cytokine IL-12p70 is crucial for T helper 1 (Th1) polarization and the generation of type 1 immunity required to fight cancer and pathogens. Therefore, strategies to optimize the production of IL-12p70 by human dendritic cells (DCs) may significantly improve the efficacy of vaccines and immunotherapies. However, the rules governing the production of IL-12p70 remain obscure. Here, we stimulated pattern recognition receptors (PRRs) representing five families of PRRs, to evaluate their ability to elicit high production of IL-12p70 by monocyte-derived DCs. We used ten well-characterized agonists and stimulated DCs in vitro with either single agonists or 27 different combinations. We found that poly(I:C), which engages the RNA-sensing PRRs TLR3 and MDA5, and LPS which stimulates TLR4, were the only agonists that could elicit notable IL-12p70 production when used as single ligands. We identified six different combinations of PRR agonists, all containing either the TLR3/MDA5 agonist poly(I:C) or the TLR7/8 agonist R848, that could synergize to elicit high production of IL-12p70 by human DCs. Five of the six combinations also triggered high production of the antiviral and antitumor cytokine IFNβ. Overall, the tested PRR ligands could be divided into three groups depending on whether they triggered production of both IL-12p70 and IFNβ, only one of the two, or neither. Thus, combinations of PRR agonists were found to increase the production of IL-12p70 by human DCs in a synergistic manner, and we identified six PRR agonist combinations that may represent strong adjuvant candidates, in particular for therapeutic cancer vaccines. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Lipid A in outer membrane vesicles shields bacteria from polymyxins.
- Author
-
Burt, Marie, Angelidou, Georgia, Mais, Christopher Nils, Preußer, Christian, Glatter, Timo, Heimerl, Thomas, Groß, Rüdiger, Serrania, Javier, Boosarpu, Gowtham, Pogge von Strandmann, Elke, Müller, Janis A., Bange, Gert, Becker, Anke, Lehmann, Mareike, Jonigk, Danny, Neubert, Lavinia, Freitag, Hinrich, Paczia, Nicole, Schmeck, Bernd, and Jung, Anna Lena
- Abstract
The continuous emergence of multidrug‐resistant bacterial pathogens poses a major global healthcare challenge, with Klebsiella pneumoniae being a prominent threat. We conducted a comprehensive study on K. pneumoniae's antibiotic resistance mechanisms, focusing on outer membrane vesicles (OMVs) and polymyxin, a last‐resort antibiotic. Our research demonstrates that OMVs protect bacteria from polymyxins. OMVs derived from Polymyxin B (PB)‐stressed K. pneumoniae exhibited heightened protective efficacy due to increased vesiculation, compared to OMVs from unstressed Klebsiella. OMVs also shield bacteria from different bacterial families. This was validated ex vivo and in vivo using precision cut lung slices (PCLS) and Galleria mellonella. In all models, OMVs protected K. pneumoniae from PB and reduced the associated stress response on protein level. We observed significant changes in the lipid composition of OMVs upon PB treatment, affecting their binding capacity to PB. The altered binding capacity of single OMVs from PB stressed K. pneumoniae could be linked to a reduction in the lipid A amount of their released vesicles. Although the amount of lipid A per vesicle is reduced, the overall increase in the number of vesicles results in an increased protection because the sum of lipid A and therefore PB binding sites have increased. This unravels the mechanism of the altered PB protective efficacy of OMVs from PB stressed K. pneumoniae compared to control OMVs. The lipid A‐dependent protective effect against PB was confirmed in vitro using artificial vesicles. Moreover, artificial vesicles successfully protected Klebsiella from PB ex vivo and in vivo. The findings indicate that OMVs act as protective shields for bacteria by binding to polymyxins, effectively serving as decoys and preventing antibiotic interaction with the cell surface. Our findings provide valuable insights into the mechanisms underlying antibiotic cross‐protection and offer potential avenues for the development of novel therapeutic interventions to address the escalating threat of multidrug‐resistant bacterial infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Campylobacter jejuni virulence factors: update on emerging issues and trends.
- Author
-
Tikhomirova, Alexandra, McNabb, Emmylee R., Petterlin, Luca, Bellamy, Georgia L., Lin, Kyaw H., Santoso, Christopher A., Daye, Ella S., Alhaddad, Fatimah M., Lee, Kah Peng, and Roujeinikova, Anna
- Subjects
CAMPYLOBACTER jejuni ,FOOD contamination ,GASTROENTERITIS - Abstract
Campylobacter jejuni is a very common cause of gastroenteritis, and is frequently transmitted to humans through contaminated food products or water. Importantly, C. jejuni infections have a range of short- and long-term sequelae such as irritable bowel syndrome and Guillain Barre syndrome. C. jejuni triggers disease by employing a range of molecular strategies which enable it to colonise the gut, invade the epithelium, persist intracellularly and avoid detection by the host immune response. The objective of this review is to explore and summarise recent advances in the understanding of the C. jejuni molecular factors involved in colonisation, invasion of cells, collective quorum sensing-mediated behaviours and persistence. Understanding the mechanisms that underpin the pathogenicity of C. jejuni will enable future development of effective preventative approaches and vaccines against this pathogen. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. The Role of TRP Channels in Sepsis and Colitis.
- Author
-
Dvornikova, Kristina A., Platonova, Olga N., and Bystrova, Elena Y.
- Subjects
TRP channels ,INFLAMMATORY bowel diseases ,SEPSIS ,COLITIS ,CROHN'S disease ,LABORATORY animals - Abstract
To date, several members of the transient receptor potential (TRP) channels which provide a wide array of roles have been found in the gastrointestinal tract (GI). The goal of earlier research was to comprehend the intricate signaling cascades that contribute to TRP channel activation as well as how these receptors' activity affects other systems. Moreover, there is a large volume of published studies describing the role of TRP channels in a number of pathological disorders, including inflammatory bowel disease (IBD) and sepsis. Nevertheless, the generalizability of these results is subject to certain limitations. For instance, the study of IBD relies on various animal models and experimental methods, which are unable to precisely imitate the multifactorial chronic disease. The diverse pathophysiological mechanisms and unique susceptibility of animals may account for the inconsistency of the experimental data collected. The main purpose of this study was to conduct a comprehensive review and analysis of existing studies on transient receptor potential (TRP) channels implicating specific models of colitis and sepsis, with particular emphasis on their involvement in pathological disorders such as IBD and sepsis. Furthermore, the text endeavors to evaluate the generalizability of experimental findings, taking into consideration the limitations posed by animal models and experimental methodologies. Finally, we also provide an updated schematic of the most important and possible molecular signaling pathways associated with TRP channels in IBD and sepsis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Vaccines and the Eye: Current Understanding of the Molecular and Immunological Effects of Vaccination on the Eye.
- Author
-
Zou, Yaru, Kamoi, Koju, Zong, Yuan, Zhang, Jing, Yang, Mingming, and Ohno-Matsui, Kyoko
- Subjects
VACCINATION complications ,VACCINATION ,MOLECULAR mimicry ,OPTIC neuritis ,VACCINE safety ,EYE inflammation ,IMMUNOGLOBULINS - Abstract
Vaccination is a public health cornerstone that protects against numerous infectious diseases. Despite its benefits, immunization implications on ocular health warrant thorough investigation, particularly in the context of vaccine-induced ocular inflammation. This review aimed to elucidate the complex interplay between vaccination and the eye, focusing on the molecular and immunological pathways implicated in vaccine-associated ocular adverse effects. Through an in-depth analysis of recent advancements and the existing literature, we explored various mechanisms of vaccine-induced ocular inflammation, such as direct infection by live attenuated vaccines, immune complex formation, adjuvant-induced autoimmunity, molecular mimicry, hypersensitivity reactions, PEG-induced allergic reactions, Type 1 IFN activation, free extracellular RNA, and specific components. We further examined the specific ocular conditions associated with vaccination, such as uveitis, optic neuritis, and retinitis, and discussed the potential impact of novel vaccines, including those against SARS-CoV-2. This review sheds light on the intricate relationships between vaccination, the immune system, and ocular tissues, offering insights into informed discussions and future research directions aimed at optimizing vaccine safety and ophthalmological care. Our analysis underscores the importance of vigilance and further research to understand and mitigate the ocular side effects of vaccines, thereby ensuring the continued success of vaccination programs, while preserving ocular health. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. In situ captured antibacterial action of membrane-incising peptide lamellae.
- Author
-
el Battioui, Kamal, Chakraborty, Sohini, Wacha, András, Molnár, Dániel, Quemé-Peña, Mayra, Szigyártó, Imola Cs., Szabó, Csenge Lilla, Bodor, Andrea, Horváti, Kata, Gyulai, Gergő, Bősze, Szilvia, Mihály, Judith, Jezsó, Bálint, Románszki, Loránd, Tóth, Judit, Varga, Zoltán, Mándity, István, Juhász, Tünde, and Beke-Somfai, Tamás
- Subjects
PEPTIDES ,BACTERIAL cell surfaces ,COMPLEX compounds ,SUPRAMOLECULES ,MOLECULAR dynamics ,PEPTIDE antibiotics - Abstract
Developing unique mechanisms of action are essential to combat the growing issue of antimicrobial resistance. Supramolecular assemblies combining the improved biostability of non-natural compounds with the complex membrane-attacking mechanisms of natural peptides are promising alternatives to conventional antibiotics. However, for such compounds the direct visual insight on antibacterial action is still lacking. Here we employ a design strategy focusing on an inducible assembly mechanism and utilized electron microscopy (EM) to follow the formation of supramolecular structures of lysine-rich heterochiral β
3 -peptides, termed lamellin-2K and lamellin-3K, triggered by bacterial cell surface lipopolysaccharides. Combined molecular dynamics simulations, EM and bacterial assays confirmed that the phosphate-induced conformational change on these lamellins led to the formation of striped lamellae capable of incising the cell envelope of Gram-negative bacteria thereby exerting antibacterial activity. Our findings also provide a mechanistic link for membrane-targeting agents depicting the antibiotic mechanism derived from the in-situ formation of active supramolecules. Inspired by the alternating chirality backbone pattern of some effective peptide antimicrobials, here authors design lysine-rich heterochiral peptides that show antimicrobial activity. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
27. Single-B cell analysis correlates high-lactate secretion with stress and increased apoptosis.
- Author
-
Bucheli, Olivia T. M., Rodrigues, Daniela, Portmann, Kevin, Linder, Aline, Thoma, Marina, Halin, Cornelia, and Eyer, Klaus
- Subjects
B cells ,CELL analysis ,SECRETION ,CELL physiology ,B cell differentiation ,APOPTOSIS - Abstract
While cellular metabolism was proposed to be a driving factor of the activation and differentiation of B cells and the function of the resulting antibody-secreting cells (ASCs), the study of correlations between cellular metabolism and functionalities has been difficult due to the absence of technologies enabling the parallel measurement. Herein, we performed single-cell transcriptomics and introduced a direct concurrent functional and metabolic flux quantitation of individual murine B cells. Our transcriptomic data identified lactate metabolism as dynamic in ASCs, but antibody secretion did not correlate with lactate secretion rates (LSRs). Instead, our study of all splenic B cells during an immune response linked increased lactate metabolism with acidic intracellular pH and the upregulation of apoptosis. T cell-dependent responses increased LSRs, and added TLR4 agonists affected the magnitude and boosted LSR
high B cells in vivo, while resulting in only a few immunoglobulin-G secreting cells (IgG-SCs). Therefore, our observations indicated that LSRhigh cells were not differentiating into IgG-SCs, and were rather removed due to apoptosis. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
28. Antibiotic Resistance Profile of Salmonella sp. Isolates from Commercial Laying Hen Farms in Central-Western Brazil.
- Author
-
Moraes, Dunya Mara Cardoso, Almeida, Ana Maria De Souza, Andrade, Maria Auxiliadora, Nascente, Eduardo de Paula, Duarte, Sabrina Castilho, Nunes, Iolanda Aparecida, Jayme, Valéria De Sá, and Minafra, Cíntia
- Subjects
DRUG resistance in bacteria ,HENS ,SALMONELLA enterica ,SALMONELLA ,THIRD generation cephalosporins ,MULTIDRUG resistance ,FOOT & mouth disease - Abstract
Microbial resistance to antibiotics poses a significant threat to both human and animal health, necessitating international efforts to mitigate this issue. This study aimed to assess the resistance profiles of Salmonella sp. isolates and identify the presence of intl1, sul1, and blaTEM resistance genes within antigenically characterized isolates, including Agona, Livingstone, Cerro, Schwarzengrund, Salmonella enterica subsp. enterica serotype O:4.5, Anatum, Enteritidis, Johannesburg, Corvallis, and Senftenberg. These isolates underwent susceptibility testing against 14 antibiotics. The highest resistance percentages were noted for sulfamethoxazole (91%), sulfonamides (51%), and ceftiofur (28.9%), while no resistance was observed for ciprofloxacin. Salmonella Johannesburg and Salmonella Corvallis showed resistance to one antibiotic, whereas other serovars were resistant to at least two. Salmonella Schwarzengrund exhibited resistance to 13 antibiotics. The intl1 gene was detected in six out of the ten serovars, and the sul1 gene in three, always co-occurring with intl1. The blaTEM gene was not identified. Our findings highlight the risk posed by the detected multiple resistances and genes to animal, human, and environmental health. The multidrug resistance, especially to third-generation cephalosporins and fluoroquinolones, highlights the need for stringent monitoring of Salmonella in laying hens. The potential of the environment, humans, eggs, and their products to act as vectors for antibiotic resistance represents a significant concern for One Health. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Anti-Inflamatory Activities of Novel Chalcone Derivatives.
- Author
-
Yalçın, Ergin, Sevin, Sedat, Uyar, Recep, and Ayaz, Furkan
- Subjects
CHALCONE ,FRIEDEL-Crafts reaction ,ANTI-inflammatory agents ,PSEUDOPOTENTIAL method ,ANTINEOPLASTIC agents ,GLIOBLASTOMA multiforme - Abstract
Objective: Design and synthesis of two chalcone derivatives, evaluation of their anticancer and antiinflamatory activities. Methods: The ring-closure through an intramolecular Friedel-Crafts reaction followed by an alkaline-catalyzed Claisen-Schmidt condensation. MTT assay was conducted in anticancer activity. The chalcone derivatives tested for anti-inflammatory immunomodulatory potential by measuring pro-inflammatory cytokines production levels. Results and Discussion: Both compounds displayed anti-inflammatory effects on activated mammalian cells without being cytotoxic. Their low toxicity resulted in high IC
50 values in glioblastoma cells, indicating they are safe anti-inflammatory agents, yet lack anti-cancer properties. Conclusions: Synthesized and characterized two chalcone derivatives that displayed comparable anti-inflammatory effects, reducing TNF, IL6, GMCSF, and IL12p40 levels without harming macrophages. Their high IC50 values in glioblastoma cells suggest low toxicity and highlight their potential as effective anti-inflammatory agents [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
30. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.
- Author
-
Shebbo, Salima, Binothman, Najat, Darwaish, Manar, Niaz, Hanan A., Abdulal, Rwaa H., Borjac, Jamilah, Hashem, Anwar M., and Mahmoud, Ahmad Bakur
- Subjects
COLORECTAL cancer ,IMMUNE checkpoint inhibitors ,CHIMERIC antigen receptors ,CANCER vaccines ,IMMUNOTHERAPY - Abstract
Colorectal cancer (CRC) is the third most common cancer globally and presents a significant challenge owing to its high mortality rate and the limitations of traditional treatment options such as surgery, radiotherapy, and chemotherapy. While these treatments are foundational, they are often poorly effective owing to tumor resistance. Immunotherapy is a groundbreaking alternative that has recently emerged and offers new hope for success by exploiting the body’s own immune system. This article aims to provide an extensive review of clinical trials evaluating the efficacy of various immunotherapies, including CRC vaccines, chimeric antigen receptor T-cell therapies, and immune checkpoint inhibitors. We also discuss combining CRC vaccines with monoclonal antibodies, delve into preclinical studies of novel cancer vaccines, and assess the impact of these treatment methods on patient outcomes. This review seeks to provide a deeper understanding of the current state of CRC treatment by evaluating innovative treatments and their potential to redefine the prognosis of patients with CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.
- Author
-
Hentzien, Maxime, Bonnet, Fabrice, Bernasconi, Enos, Biver, Emmanuel, Braun, Dominique L., Munting, Aline, Leuzinger, Karoline, Leleux, Olivier, Musardo, Stefano, Prendki, Virginie, Schmid, Patrick, Staehelin, Cornelia, Stoeckle, Marcel, Walti, Carla S., Wittkop, Linda, Appay, Victor, Didierlaurent, Arnaud M., and Calmy, Alexandra
- Subjects
HERPES zoster vaccines ,HIV-positive persons ,HERPES zoster ,IMMUNE response ,VACCINE effectiveness ,NEUTRALIZATION tests ,IMMUNOSUPPRESSION - Abstract
Background: The burden of herpes zoster (shingles) virus and associated complications, such as post-herpetic neuralgia, is higher in older adults and has a significant impact on quality of life. The incidence of herpes zoster and post-herpetic neuralgia is increased in people living with HIV (PLWH) compared to an age-matched general population, including PLWH on long-term antiretroviral therapy (ART) with no detectable viremia and normal CD4 counts. PLWH – even on effective ART may- exhibit sustained immune dysfunction, as well as defects in cells involved in the response to vaccines. In the context of herpes zoster, it is therefore important to assess the immune response to varicella zoster virus vaccination in older PLWH and to determine whether it significantly differs to that of HIV-uninfected healthy adults or younger PLWH. We aim at bridging these knowledge gaps by conducting a multicentric, international, non-randomised clinical study (SHINGR'HIV) with prospective data collection after vaccination with an adjuvant recombinant zoster vaccine (RZV) in two distinct populations: in PLWH on long-term ART (> 10 years) over 50 years of and age/gender matched controls. Methods: We will recruit participants from two large established HIV cohorts in Switzerland and in France in addition to age-/gender-matched HIV-uninfected controls. Participants will receive two doses of RZV two months apart. In depth-evaluation of the humoral, cellular, and innate immune responses and safety profile of the RZV will be performed to address the combined effect of aging and potential immune deficiencies due to chronic HIV infection. The primary study outcome will compare the geometric mean titer (GMT) of gE-specific total IgG measured 1 month after the second dose of RZV between different age groups of PLWH and between PLWH and age-/gender-matched HIV-uninfected controls. Discussion: The SHINGR'HIV trial will provide robust data on the immunogenicity and safety profile of RZV in older PLWH to support vaccination guidelines in this population. Trial registration: ClinicalTrials.gov NCT05575830. Registered on 12 October 2022. Eu Clinical Trial Register (EUCT number 2023-504482-23-00). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Novel adjuvants in allergen-specific immunotherapy: where do we stand?
- Author
-
Yen-Ju Lin, Zimmermann, Jennifer, and Schülke, Stefan
- Subjects
VIRUS-like particles ,IMMUNOTHERAPY ,IMMUNE response ,ALUMINUM hydroxide ,FLAGELLIN - Abstract
Type I hypersensitivity, or so-called type I allergy, is caused by Th2-mediated immune responses directed against otherwise harmless environmental antigens. Currently, allergen-specific immunotherapy (AIT) is the only disease-modifying treatment with the potential to re-establish clinical tolerance towards the corresponding allergen(s). However, conventional AIT has certain drawbacks, including long treatment durations, the risk of inducing allergic side effects, and the fact that allergens by themselves have a rather low immunogenicity. To improve AIT, adjuvants can be a powerful tool not only to increase the immunogenicity of co-applied allergens but also to induce the desired immune activation, such as promoting allergen-specific Th1- or regulatory responses. This review summarizes the knowledge on adjuvants currently approved for use in human AIT: aluminum hydroxide, calcium phosphate, microcrystalline tyrosine, and MPLA, as well as novel adjuvants that have been studied in recent years: oil-in-water emulsions, virus-like particles, viral components, carbohydrate-based adjuvants (QS-21, glucans, and mannan) and TLR-ligands (flagellin and CpG-ODN). The investigated adjuvants show distinct properties, such as prolonging allergen release at the injection site, inducing allergen-specific IgG production while also reducing IgE levels, as well as promoting differentiation and activation of different immune cells. In the future, better understanding of the immunological mechanisms underlying the effects of these adjuvants in clinical settings may help us to improve AIT. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Targeting host-specific metabolic pathways--opportunities and challenges for anti-infective therapy.
- Author
-
Konaklieva, Monika I. and Plotkin, Balbina J.
- Published
- 2024
- Full Text
- View/download PDF
34. Use of Monoglycerides and Diglycerides to Mitigate Poultry Production Losses: A Review.
- Author
-
Appleton, Stacie R., Ballou, Anne, and Watkins, Kevin L.
- Subjects
PRODUCTION losses ,DIGLYCERIDES ,MONOGLYCERIDES ,POULTRY ,POULTRY as food ,TUMOR necrosis factors - Abstract
Simple Summary: This review summarizes the available literature on the impact of monoglycerides and diglycerides on poultry productivity and health. Consumption of poultry meat and eggs continues to increase in all geographies. Monoglycerides and diglycerides are products that producers can use to help fill the demand for their products while meeting the needs of today's consumers, retailers, and policymakers. Consumer preference dictates not only what food is consumed but also how that food is produced. Ingredients in livestock feed that are not antibiotics, not genetically modified, and not of animal origin but that are nutrient-like tend to be more acceptable to consumers, retailers, and producers. Mono- and diglycerides (MDG) fit these criteria, are commonly used in food, and are generally recognized as safe. But beyond being emulsifiers and a source of energy, MDG are also known to have antimicrobial, immune, and microbiome modulation and angiogenic activity. MDG in broiler diets have been shown to impact a variety of immune-related functions such as the regulation of circulating antibodies, as well as decreased gene expression or protein concentration of pro-inflammatory cytokines like TNF-α, IL-1β, IL-6, and IFN-γ. In addition, MDG can affect metabolic function and intestinal integrity. Results of this review show that MDG can serve as antimicrobial and growth-supporting alternatives for reducing poultry production losses, improving resource utilization and meeting consumer demand for sustainably produced and safe animal protein. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. First Report of Colistin-Resistant Escherichia coli Carrying mcr-1 IncI2(delta) and IncX4 Plasmids from Camels (Camelus dromedarius) in the Gulf Region.
- Author
-
Ghazawi, Akela, Strepis, Nikolaos, Anes, Febin, Yaaqeib, Dana, Ahmed, Amal, AlHosani, Aysha, AlShehhi, Mirah, Manzoor, Ashrat, Habib, Ihab, Wani, Nisar A., Hays, John P., and Khan, Mushtaq
- Subjects
CAMELS ,CAMEL milk ,MOBILE genetic elements ,ESCHERICHIA coli ,PLASMIDS ,WHOLE genome sequencing - Abstract
Addressing the emergence of antimicrobial resistance (AMR) poses a significant challenge in veterinary and public health. In this study, we focused on determining the presence, phenotypic background, and genetic epidemiology of plasmid-mediated colistin resistance (mcr) in Escherichia coli bacteria isolated from camels farmed in the United Arab Emirates (UAE). Fecal samples were collected from 50 camels at a Dubai-based farm in the UAE and colistin-resistant Gram-negative bacilli were isolated using selective culture. Subsequently, a multiplex PCR targeting a range of mcr-genes, plasmid profiling, and whole-genome sequencing (WGS) were conducted. Eleven of fifty camel fecal samples (22%) yielded colonies positive for E. coli isolates carrying the mcr-1 gene on mobile genetic elements. No other mcr-gene variants and no chromosomally located colistin resistance genes were detected. Following plasmid profiling and WGS, nine E. coli isolates from eight camels were selected for in-depth analysis. E. coli sequence types (STs) identified included ST7, ST21, ST24, ST399, ST649, ST999, and STdaa2. Seven IncI2(delta) and two IncX4 plasmids were found to be associated with mcr-1 carriage in these isolates. These findings represent the first identification of mcr-1-carrying plasmids associated with camels in the Gulf region. The presence of mcr-1 in camels from this region was previously unreported and serves as a novel finding in the field of AMR surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice.
- Author
-
Yufang Ding, Yanagi, Karin, Fang Yang, Callaway, Evelyn, Cheng, Clint, Hensel, Martha E., Menon, Rani, Alaniz, Robert C., Kyongbum Lee, and Jayaraman, Arul
- Published
- 2024
- Full Text
- View/download PDF
37. Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity.
- Author
-
Wold, Christian Winther, Christopoulos, Panagiotis F., Arias, Maykel A., Dzovor, Deborah Elikplim, Øynebråten, Inger, Corthay, Alexandre, and Inngjerdingen, Kari Tvete
- Subjects
TOLL-like receptor agonists ,ANTINEOPLASTIC agents ,PATTERN perception receptors ,CANCER cell growth ,POLYSACCHARIDES ,BETA-glucans ,TUMOR necrosis factors - Abstract
Fungal polysaccharides can exert immunomodulating activity by triggering pattern recognition receptors (PRRs) on innate immune cells such as macrophages. Here, we evaluate six polysaccharides isolated from the medicinal fungus Inonotus obliquus for their ability to activate mouse and human macrophages. We identify two water-soluble polysaccharides, AcF1 and AcF3, being able to trigger several critical antitumor functions of macrophages. AcF1 and AcF3 activate macrophages to secrete nitric oxide and the pro-inflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). Combined with interferon-γ, the fungal polysaccharides trigger high production of IL-12p70, a central cytokine for antitumor immunity, and induce macrophage-mediated inhibition of cancer cell growth in vitro and in vivo. AcF1 and AcF3 are strong agonists of the PRRs Toll-like receptor 2 (TLR2) and TLR4, and weak agonists of Dectin-1. In comparison, two prototypical particulate β-glucans, one isolated from I. obliquus and one from Saccharomyces cerevisiae (zymosan), are agonists for Dectin-1 but not TLR2 or TLR4, and are unable to trigger anti-cancer functions of macrophages. We conclude that the water-soluble polysaccharides AcF1 and AcF3 from I. obliquus have a strong potential for cancer immunotherapy by triggering multiple PRRs and by inducing potent anti-cancer activity of macrophages. Two water soluble polysaccharides from the white rot fungus Inonotus obliquus mount a potent anti-tumour response by inducing anti-cancer activity of macrophages, hence can be strong candidates for cancer immunotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions.
- Author
-
Wang, Guangyu, Wang, Yongkang, and Ma, Fang
- Subjects
IMMUNOLOGICAL adjuvants ,PATTERN perception receptors ,EMERGING infectious diseases ,IMMUNOTHERAPY ,TOLL-like receptors - Abstract
Vaccination is a valid strategy to prevent and control newly emerging and reemerging infectious diseases in humans and animals. However, synthetic and recombinant antigens are poor immunogenic to stimulate efficient and protective host immune response. Immunostimulants are indispensable factors of vaccines, which can promote to trigger fast, robust, and long-lasting immune responses. Importantly, immunotherapy with immunostimulants is increasing proved to be an effective and promising treatment of cancer, which could enhance the function of the immune system against tumor cells. Pattern recognition receptors (PRRs) play vital roles in inflammation and are central to innate and adaptive immune responses. Toll-like receptors (TLRs)-targeting immunostimulants have become one of the hotspots in adjuvant research and cancer therapy. Bacterial-origin immunoreactive molecules are usually the ligands of PRRs, which could be fast recognized by PRRs and activate immune response to eliminate pathogens. Varieties of bacterial immunoreactive molecules and bacterial component-mimicking molecules have been successfully used in vaccines and clinical therapy so far. This work provides a comprehensive review of the development, current state, mechanisms, and applications of bacterial-origin immunostimulants. The exploration of bacterial immunoreactive molecules, along with their corresponding mechanisms, holds immense significance in deepening our understanding of bacterial pathogenicity and in the development of promising immunostimulants. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Gram-negative bacterial sRNAs encapsulated in OMVs: an emerging class of therapeutic targets in diseases.
- Author
-
Ajam-Hosseini, Mobarakeh, Akhoondi, Fatemeh, Parvini, Farshid, and Fahimi, Hossein
- Abstract
Small regulatory RNAs (sRNAs) encapsulated in outer membrane vesicles (OMVs) are critical post-transcriptional regulators of gene expression in prokaryotic and eukaryotic organisms. OMVs are small spherical structures released by Gramnegative bacteria that serve as important vehicles for intercellular communication and can also play an important role in bacterial virulence and host-pathogen interactions. These molecules can interact with mRNAs or proteins and affect various cellular functions and physiological processes in the producing bacteria. This review aims to provide insight into the current understanding of sRNA localization to OMVs in Gram-negative bacteria and highlights the identification, characterization and functional implications of these encapsulated sRNAs. By examining the research gaps in this field, we aim to inspire further exploration and progress in investigating the potential therapeutic applications of OMV-encapsulated sRNAs in various diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Characterisation of colistin resistance in Gram-negative microbiota of pregnant women and neonates in Nigeria.
- Author
-
Portal, E. A. R., Sands, K., Farley, C., Boostrom, I., Jones, E., Barrell, M., Carvalho, M. J., Milton, R., Iregbu, K., Modibbo, F., Uwaezuoke, S., Akpulu, C., Audu, L., Edwin, C., Yusuf, A. H., Adeleye, A., Mukkadas, A. S., Maduekwe, D., Gambo, S., and Sani, J.
- Abstract
A mobile colistin resistance gene mcr was first reported in 2016 in China and has since been found with increasing prevalence across South-East Asia. Here we survey the presence of mcr genes in 4907 rectal swabs from mothers and neonates from three hospital sites across Nigeria; a country with limited availability or history of colistin use clinically. Forty mother and seven neonatal swabs carried mcr genes in a range of bacterial species: 46 Enterobacter spp. and single isolates of; Shigella, E. coli and Klebsiella quasipneumoniae. Ninety percent of the genes were mcr-10 (n = 45) we also found mcr-1 (n = 3) and mcr-9 (n = 1). While the prevalence during this collection (2015-2016) was low, the widespread diversity of mcr-gene type and range of bacterial species in this sentinel population sampling is concerning. It suggests that agricultural colistin use was likely encouraging sustainment of mcr-positive isolates in the community and implementation of medical colistin use will rapidly select and expand resistant isolates.Here, the authors report the results of a BARNARDS sub-study identifying a 1% mobile colistin resistance gene (mcr) carriage rate in around 5000 rectal swabs from mothers and neonates across Nigeria, of which 90% were mcr-10 (mostly Enterobacter spp.) and 10% were mcr-1 and mcr9. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Radiation-Detoxified Form of Endotoxin Effectively Activates Th 1 Responses and Attenuates Ragweed-Induced Th 2 -Type Airway Inflammation in Mice.
- Author
-
Bácsi, Attila, Ágics, Beatrix, Pázmándi, Kitti, Kocsis, Béla, Sándor, Viktor, Bertók, Lóránd, Bruckner, Geza, and Sipka, Sándor
- Subjects
ENDOTOXINS ,MICE ,ENVIRONMENTAL exposure ,INFLAMMATION ,LIPOPOLYSACCHARIDES ,DENDRITIC cells ,T cells ,ALLERGIES - Abstract
Urbanization with reduced microbial exposure is associated with an increased burden of asthma and atopic symptoms. Conversely, environmental exposure to endotoxins in childhood can protect against the development of allergies. Our study aimed to investigate whether the renaturation of the indoor environment with aerosolized radiation-detoxified lipopolysaccharide (RD-LPS) has a preventative effect against the development of ragweed-induced Th
2 -type airway inflammation. To explore this, cages of six-week-old BALB/c mice were treated daily with aerosolized native LPS (N-LPS) or RD-LPS. After a 10-week treatment period, mice were sensitized and challenged with ragweed pollen extract, and inflammatory cell infiltration into the airways was observed. As dendritic cells (DCs) play a crucial role in the polarization of T-cell responses, in our in vitro experiments, the effects of N-LPS and RD-LPS were compared on human monocyte-derived DCs (moDCs). Mice in RD-LPS-rich milieu developed significantly less allergic airway inflammation than mice in N-LPS-rich or common environments. The results of our in vitro experiments demonstrate that RD-LPS-exposed moDCs have a higher Th1 -polarizing capacity than moDCs exposed to N-LPS. Consequently, we suppose that the aerosolized, non-toxic RD-LPS applied in early life for the renaturation of urban indoors may be suitable for the prevention of Th2 -mediated allergies in childhood. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
42. Aquibaculum sediminis sp. nov., a halotolerant bacteria isolated from salt lake sediment.
- Author
-
Xu QY, Gao L, Wu D, Li XY, Liu YH, Zhang Y, Chen YH, She TT, Fang BZ, and Li WJ
- Subjects
- China, Bacterial Typing Techniques, Fatty Acids analysis, Sodium Chloride metabolism, Phospholipids analysis, Sequence Analysis, DNA, Geologic Sediments microbiology, Phylogeny, Lakes microbiology, RNA, Ribosomal, 16S genetics, DNA, Bacterial genetics, Base Composition
- Abstract
An aerobic, Gram-stain negative bacterium was isolated from sediment samples of Barkol salt lake in Hami City, Xinjiang Uygur Autonomous Region, China, with the number EGI_FJ10229
T . The strain is ellipse-shaped, oxidase-negative, catalase-positive, and has white, round, smooth, opaque colonies on marine 2216 E agar plate. Growth occurs at 4.0-37.0 ℃ (optimal:30.0 ℃), pH 7.0-9.0 (optimal: pH 8.0) and NaCl concentration of 0-8.0% (optimal: 3.0%). Phylogenetic analysis based on 16S rRNA gene and genome sequences indicated that the isolated strain should be assigned to the genus Aquibaculum and was most closely related to Aquibaculum arenosum CAU 1616T . Average nucleotide identity (ANI) and Average amino-acid identity (AAI) values between the type species of the genus Aquibaculum and other related type species were lower than the threshold values recommended for bacterial species. The genomic DNA G + C content of EGI_FJ10229T was 65.41%. The major polar lipids were diphosphatidylglycerol, phosphatidylmethylethanolamine, phosphatidylcholine, phosphatidylethanolamine and unidentified phospholipid. The major fatty acids (> 5%) were C19:0 cyclo ω8c (42.0%) and C18:1 ω7c (33.78%). The respiratory quinone identified was Q-10. Differential phenotypic and genotypic characteristics of this strain and species of genus Aquibaculum showed that the strain should be classified as representing a new species belonging to this genus, for which the name Aquibaculum sediminis sp. nov. is proposed. The type strain of the proposed novel species is EGI_FJ10229T (= KCTC 8570T = GDMCC 1.4598T )., (© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.)- Published
- 2024
- Full Text
- View/download PDF
43. Exposure to Mycobacterium remodels alveolar macrophages and the early innate response to Mycobacterium tuberculosis infection.
- Author
-
Mai, Dat, Jahn, Ana, Murray, Tara, Morikubo, Michael, Lim, Pamelia N., Cervantes, Maritza M., Pham, Linh K., Nemeth, Johannes, Urdahl, Kevin, Diercks, Alan H., Aderem, Alan, and Rothchild, Alissa C.
- Subjects
ALVEOLAR macrophages ,MYCOBACTERIUM bovis ,MYCOBACTERIUM tuberculosis ,MYCOBACTERIAL diseases ,MYCOBACTERIUM ,IMMUNOLOGIC memory ,MYELOID cells ,TUBERCULOSIS in cattle - Abstract
Alveolar macrophages (AMs) play a critical role during Mycobacterium tuberculosis (Mtb) infection as the first cells in the lung to encounter bacteria. We previously showed that AMs initially respond to Mtb in vivo by mounting a cell-protective, rather than pro-inflammatory response. However, the plasticity of the initial AM response was unknown. Here, we characterize how previous exposure to Mycobacterium, either through subcutaneous vaccination with Mycobacterium bovis (scBCG) or through a contained Mtb infection (coMtb) that mimics aspects of concomitant immunity, impacts the initial response by AMs. We find that both scBCG and coMtb accelerate early innate cell activation and recruitment and generate a stronger pro-inflammatory response to Mtb in vivo by AMs. Within the lung environment, AMs from scBCG vaccinated mice mount a robust interferon-associated response, while AMs from coMtb mice produce a broader inflammatory response that is not dominated by Interferon Stimulated Genes. Using scRNAseq, we identify changes to the frequency and phenotype of airway-resident macrophages following Mycobacterium exposure, with enrichment for both interferon-associated and pro-inflammatory populations of AMs. In contrast, minimal changes were found for airway-resident T cells and dendritic cells after exposures. Ex vivo stimulation of AMs with Pam3Cys, LPS and Mtb reveal that scBCG and coMtb exposures generate stronger interferon-associated responses to LPS and Mtb that are cell-intrinsic changes. However, AM profiles that were unique to each exposure modality following Mtb infection in vivo are dependent on the lung environment and do not emerge following ex vivo stimulation. Overall, our studies reveal significant and durable remodeling of AMs following exposure to Mycobacterium, with evidence for both AM-intrinsic changes and contributions from the altered lung microenvironments. Comparisons between the scBCG and coMtb models highlight the plasticity of AMs in the airway and opportunities to target their function through vaccination or host-directed therapies. Author summary: Tuberculosis, a disease caused by the bacteria Mycobacterium tuberculosis (Mtb), claims around 1.6 million lives each year, making it one of the leading causes of death worldwide by an infectious agent. Based on principles of conventional immunological memory, prior exposure to either Mtb or M. bovis BCG leads to antigen-specific long-lasting changes to the adaptive immune response that can be effective at protecting against subsequent challenge. However, how these exposures may also impact the innate immune response is less understood. Alveolar macrophages are tissue-resident myeloid cells that play an important role during Mtb infection as innate immune sentinels in the lung and the first host cells to respond to infection. Here, we examined how prior Mycobacterium exposure, either through BCG vaccination or a model of contained Mtb infection, impacts the early innate response by alveolar macrophages. We find that prior exposure remodels the alveolar macrophage response to Mtb through both cell-intrinsic changes and signals that depend on the altered lung environment. These findings suggest that the early innate immune response could be targeted through vaccination or host-directed therapy and could complement existing strategies to enhance the host response to Mtb. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview.
- Author
-
Hoque Kayesh, Mohammad Enamul, Michinori Kohara, and Kyoko Tsukiyama-Kohara
- Subjects
VIRUS diseases ,FLAVIVIRUSES ,HIV ,INFLUENZA viruses ,HEPATITIS C virus ,WEST Nile virus ,EMERGING infectious diseases - Abstract
Tol-like receptor (TLR) agonists, as potent adjuvants, have gained attention in vaccine research for their ability to enhance immune responses. This study focuses on their application in improving vaccine efficacy against key viral infections, including hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), SARS-CoV-2, influenza virus, and flaviviruses, including West Nile virus, dengue virus, and chikungunya virus. Vaccines are crucial in preventing microbial infections, including viruses, and adjuvants play a vital role in modulating immune responses. However, there are still many diseases for which effective vaccines are lacking or have limited immune response, posing significant threats to human health. The use of TLR agonists as adjuvants in viral vaccine formulations holds promise in improving vaccine effectiveness. By tailoring adjuvants to specific pathogens, such as HBV, HCV, HIV, SARS-CoV-2, influenza virus, and flavivirus, protective immunity against chronic and emerging infectious disease can be elicited. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. LITAF protects against pore-forming protein–induced cell death by promoting membrane repair.
- Author
-
Stefani, Caroline, Bruchez, Anna M., Rosasco, Mario G., Yoshida, Anna E., Fasano, Kayla J., Levan, Paula F., Lorant, Alina, Hubbard, Nicholas W., Oberst, Andrew, Stuart, Lynda M., and Lacy-Hulbert, Adam
- Subjects
TRANSPOSONS ,CELL death ,BACTERIAL toxins ,CYTOTOXINS ,GENETIC regulation ,CELL membranes ,TOXIC shock syndrome - Abstract
Pore-forming toxins (PFTs) are the largest class of bacterial toxins and contribute to virulence by triggering host cell death. Vertebrates also express endogenous pore-forming proteins that induce cell death as part of host defense. To mitigate damage and promote survival, cells mobilize membrane repair mechanisms to neutralize and counteract pores, but how these pathways are activated is poorly understood. Here, we use a transposon-based gene activation screen to discover pathways that counteract the cytotoxicity of the archetypal PFT Staphylococcus aureus α-toxin. We identify the endolysosomal protein LITAF as a mediator of cellular resistance to PFT-induced cell death that is active against both bacterial toxins and the endogenous pore, gasdermin D, a terminal effector of pyroptosis. Activation of the ubiquitin ligase NEDD4 by potassium efflux mobilizes LITAF to recruit the endosomal sorting complexes required for transport (ESCRT) machinery to repair damaged membrane. Cells lacking LITAF, or carrying naturally occurring disease-associated mutations of LITAF, are highly susceptible to pore-induced death. Notably, LITAF-mediated repair occurs at endosomal membranes, resulting in expulsion of damaged membranes as exosomes, rather than through direct excision of pores from the surface plasma membrane. These results identify LITAF as a key effector that links sensing of cellular damage to repair. Editor's summary: Membrane pores caused by bacterial pore-forming toxins (PFTs) or endogenous pore-forming proteins can trigger cell death. Membrane repair machinery can promote cell survival and resistance to PFTs, but the cellular mechanisms underlying defense against these toxins are not well defined. Stefani et al. performed a transposon mutagenesis screen to identify genes involved in resistance to Staphylococcus aureus α-toxin–induced cell death. They identified that LITAF, an endolysosomal protein, was required for cell survival after α-toxin– and gasdermin D–induced cell death. K
+ efflux through membrane pores promoted LITAF localization to endosomes containing α-toxin and initiated assembly of ESCRT machinery, resulting in secretion of damaged membrane in exosomes. This work uncovers a key role for LITAF in sensing plasma membrane damage and activating membrane repair machinery. —Hannah Isles [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
46. Investigation of the Molecular Interactions of Vaccine Adjuvants: Can a Strategic Trio of Toll-like Receptor Agonists Enhance Efficacy in a Multifaceted Approach?
- Author
-
Ozverel, Cenk Serhan and Erdag, Emine
- Subjects
TOLL-like receptors ,MOLECULAR dynamics ,MOLECULAR docking ,IMMUNOLOGICAL adjuvants ,VACCINE development - Abstract
Background: The imperative need for effective vaccines against viral diseases has intensified research on adjuvants to enhance immune responses. Toll-like receptor (TLR) agonists, such as Imiquimod, Resiquimod, and CpG oligodeoxynucleotides (CpG ODN), are some crucial components in vaccine formulations. This study investigated the molecular interactions and binding affinities of TLR4, TLR7/8, and TLR9 agonists, through in silico techniques. Methods: The three-dimensional structure of human TLR9 was predicted using Iterative Threading ASSEmbly Refinement. Homology modeling was employed using a multi-step approach to generate the human TLR9 model including template identification, ab initio modeling, iterative refinement, and final model generation of the crystallographic structure. Molecular docking and simulation studies were performed using AutoDock Vina, HDOCK, and GROningen MAchine for Chemical Simulations tools. The molecular docking study revealed binding sites and binding affinities of adjuvants in the binding regions of target TLRs. Molecular dynamics simulations and Molecular Mechanics/Poisson-Boltzmann Surface Area calculations ascertain the stability and binding energies of the TLR-adjuvant complexes. Results: Results indicate distinct interactions, with Resiquimod showing superior affinity toward TLR7. QS21, on the other hand, emerged as a potent TLR4 agonist, while CpG ODN 2006 binds specifically to TLR9. The study proposes a strategic combination of QS21, Resiquimod, and CpG ODN 2006 as a potential adjuvant system, offering a multifaceted approach to enhance vaccine efficacy. Conclusions: This study furnishes preliminary data and establishes the foundational framework for subsequent inquiries encompassing both in vitro and in vivo studies concerning vaccine adjuvant systems. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Accumulation and toxicity of biologically produced gold nanoparticles in different types of specialized mammalian cells.
- Author
-
Pourali P, Svoboda M, Neuhöferová E, Dzmitruk V, and Benson V
- Subjects
- Animals, Mice, NIH 3T3 Cells, RAW 264.7 Cells, Cell Survival drug effects, Fusarium metabolism, Macrophages metabolism, Macrophages drug effects, Gold chemistry, Gold metabolism, Gold pharmacology, Metal Nanoparticles chemistry
- Abstract
The biologically produced gold nanoparticles (AuNPs) are novel carriers with promising use in targeted tumor therapy. Still, there are no studies regarding the efficacy of nanoparticle internalization by cancer and noncancer cells. In this study, AuNPs were produced by Fusarium oxysporum and analyzed by spectrophotometry, transmission electron microscopy (TEM), energy dispersive x-ray spectroscopy (EDS), and Zetasizer. Obtained AuNPs were about 15 nm in size with a zeta potential of -35.8 mV. The AuNPs were added to cancer cells (4T1), noncancer cells (NIH/3T3), and macrophages (RAW264.7). The viability decreased in 4T1 (77 ± 3.74%) in contrast to NIH/3T3 and RAW264.7 cells (89 ± 4.9% and 90 ± 3.5%, respectively). The 4T1 cancer cells also showed the highest uptake and accumulation of Au (∼80% of AuNPs was internalized) as determined by graphite furnace atomic absorption spectroscopy. The lowest amount of AuNPs was internalized by the NIH/3T3 cells (∼30%). The NIH/3T3 cells exhibited prominent reorganization of F-actin filaments as examined by confocal microscopy. In RAW264.7, we analyzed the release of proinflammatory cytokines by flow cytometry and we found the AuNP interaction triggered transient secretion of tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ). In summary, we proved the biologically produced AuNPs entered all the tested cell types and triggered cell-specific responses. High AuNP uptake by tumor cells was related to decreased cell viability, while low nanoparticle uptake by fibroblasts triggered F-actin reorganization without remarkable toxicity. Thus, the biologically produced AuNPs hold promising potential as cancer drug carriers and likely require proper surface functionalization to shield phagocytizing cells., (© 2024 The Authors. Biotechnology and Applied Biochemistry published by Wiley Periodicals LLC on behalf of International Union of Biochemistry and Molecular Biology.)
- Published
- 2024
- Full Text
- View/download PDF
48. Temporin-GHaR Peptide Alleviates LPS-Induced Cognitive Impairment and Microglial Activation by Modulating Endoplasmic Reticulum Stress.
- Author
-
Zhang DQ, Dong X, Su S, Zhang L, Zhang J, Yang W, Hu W, Li L, Song Y, Xie X, Li Q, Wang R, and Zhang Y
- Abstract
Neuroinflammation is considered an important factor that leads to cognitive impairment. Microglia play a crucial role in neuroinflammation, which leads to cognitive impairment. This study aimed at determining whether temporin-GHaR peptide (GHaR) could improve cognitive function and at uncovering the underlying mechanisms. We found that GHaR treatment alleviated LPS-induced cognitive impairment and inhibited activation of microglia in LPS-induced mice. Furthermore, GHaR inhibited activation of endoplasmic reticulum stress (ERS) and the NF-κB signaling pathway in LPS-induced mice. In vitro, GHaR inhibited M1 polarization of BV2 cells and suppressed TNF-α and IL-6 secretion. Additionally, GHaR neuronal cell viability and apoptosis were induced by LPS-activated microglia-conditioned medium. Moreover, in LPS-induced BV2 cells, GHaR inhibited activation of ERS and the NF-κB signaling pathway. In summary, GHaR improved LPS-induced cognitive and attenuated inflammatory responses via microglial activation reversal. In conclusion, the neuroprotective effects of GHaR were mediated via the ERS signaling pathway., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
49. Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant.
- Author
-
Jin H, Ji Y, An J, Ha DH, Lee YR, Kim HJ, Lee CG, Jeong W, Kwon IC, Yang EG, Kim KH, Lee C, and Chung HS
- Subjects
- Humans, Escherichia coli genetics, COVID-19 Vaccines, Pandemics, Adjuvants, Immunologic, Adjuvants, Vaccine, Vaccines, Lipid A analogs & derivatives
- Abstract
During the COVID-19 pandemic, expedient vaccine production has been slowed by the shortage of safe and effective raw materials, such as adjuvants, essential components to enhance the efficacy of vaccines. Monophosphoryl lipid A (MPLA) is a potent and safe adjuvant used in human vaccines, including the Shingles vaccine, Shingrix. 3-O-desacyl-4'-monophosphoryl lipid A (MPL), a representative MPLA adjuvant commercialized by GSK, was prepared via chemical conversion of precursors isolated from Salmonella typhimurium R595. However, the high price of these materials limits their use in premium vaccines. To combat the scarcity and high cost of safe raw materials for vaccines, we need to develop a feasible MPLA production method that is easily scaled up to meet industrial requirements. In this study, we engineered peptidoglycan and outer membrane biosynthetic pathways in Escherichia coli and developed a Escherichia coli strain, KHSC0055, that constitutively produces EcML (E. coli-produced monophosphoryl lipid A) without additives such as antibiotics or overexpression inducers. EcML production was optimized on an industrial scale via high-density fed-batch fermentation, and obtained 2.7 g of EcML (about 135,000 doses of vaccine) from a 30-L-scale fermentation. Using KHSC0055, we simplified the production process and decreased the production costs of MPLA. Then, we applied EcML purified from KHSC0055 as an adjuvant for a COVID-19 vaccine candidate (EuCorVac-19) currently in clinical trial stage III in the Philippines. By probing the efficacy and safety of EcML in humans, we established KHSC0055 as an efficient cell factory for MPLA adjuvant production., (© 2023 Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
50. Evolution and genomic profile of Salmonella enterica serovar Gallinarum biovar Pullorum isolates from Brazil.
- Author
-
Kipper D, De Carli S, de Souza Zanetti N, Mascitti AK, Kazantzi Fonseca AS, Ikuta N, and Lunge VR
- Subjects
- Brazil epidemiology, Animals, Phylogeny, Genome, Bacterial, Serogroup, Evolution, Molecular, Poultry Diseases microbiology, Poultry Diseases epidemiology, Salmonella Infections, Animal microbiology, Salmonella Infections, Animal epidemiology, Chickens, Salmonella enterica genetics, Salmonella enterica drug effects
- Abstract
Salmonella enterica subspecies enterica serovar Gallinarum biovar Pullorum ( S. Pullorum) is a pathogenic bacterium that causes Pullorum disease (PD). PD is an acute systemic disease that affects young chickens, causing white diarrhea and high mortality. Although many sanitary programs have been carried out to eradicate S. Pullorum, PD outbreaks have been reported in different types of birds (layers, broilers, breeders) worldwide. This study aimed to evaluate the evolution and genetic characteristics of S. Pullorum isolated from PD in Brazil. Phylogenetic analysis of S. Pullorum genomes sequenced in this study and available genomic databases demonstrated that all isolates from Brazil are from sequence type 92 (ST92) and cluster into two lineages (III and IV). ColpVC, IncFIC(FII), and IncFII(S) were plasmid replicons frequently found in the Brazilian lineages. Two resistance genes ( aac(6 ' )-Iaa , conferring resistance to aminoglycoside, disinfecting agents, and antiseptics ( mdf(A) ) and tetracycline ( mdf(A) ) were detected frequently. Altogether, these results are important to understand the circulation of S. Pullorum and, consequently, to develop strategies to reduce losses due to PD.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.